MAP2K7 and breast carcinoma: More importantly, we also identified the Wnt/β-catenin and ERK/MEK signaling pathways as potential molecular mechanisms by which these SCFAs exert their effects, thus rendering them potential players in the development of targeted therapeutic strategies against breast cancer.